Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Titel:
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Auteur:
Clément, Karine van den Akker, Erica Argente, Jesús Bahm, Allison Chung, Wendy K Connors, Hillori De Waele, Kathleen Farooqi, I Sadaf Gonneau-Lejeune, Julie Gordon, Gregory Kohlsdorf, Katja Poitou, Christine Puder, Lia Swain, James Stewart, Murray Yuan, Guojun Wabitsch, Martin Kühnen, Peter